Skip to main content



Local Cdiff information for Louisiana

Louisiana

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Louisiana.



Local Cdiff information for Louisiana

Louisiana

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Louisiana.

Providers

Dr. Arnab Ray, MD

Director, GI Fellowship Program and Section Head, General Gastroenterology
Ochsner Clinical Foundation, Department of Gastroenterology
1514 Jefferson Highway
New Orleans, 70121
(504) 842-4015
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1138
Hospital Onset: 1138
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.74
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Erica Washington, MPH
Louisiana Department of Health & Hospitals
Office of Public Health
1450 Poydras St., Ste. 2155
New Orleans, 70112
(504) 568-8319
(504) 548-8290
EMAIL ERICA WASHINGTON, MPH >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older